Stay updated on Nintedanib IPF Trial: Twice Daily vs Placebo
Sign up to get notified when there's something new on the Nintedanib IPF Trial: Twice Daily vs Placebo page.

Latest updates to the Nintedanib IPF Trial: Twice Daily vs Placebo page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe study page now shows recruitment is closed ('No longer looking for participants') and adds new help sections (How to Read a Study Record, Common Questions, How to Join a Study), while updating the Intervention/Treatment heading formatting and the revision tag to v3.6.0.SummaryDifference0.4%

- Check16 days agoChange DetectedA new revision stamp, Revision: v3.5.5, has been added to the page. Several non-critical terms and navigation labels were removed, narrowing the study record presentation.SummaryDifference17%

- Check38 days agoChange DetectedThe revision tag on the page changed from v3.5.3 to v3.5.4, signaling an internal update to the page's versioning. This metadata-level change does not alter the study content or visible information.SummaryDifference0.0%

- Check59 days agoChange DetectedThe page’s supplementary resources section and related footer/disclaimer items were updated, and the interface/version label changed from an earlier revision to a newer one.SummaryDifference0.2%

- Check88 days agoChange DetectedRemoved the Genetic and Rare Diseases Information Center from Resources and removed the Interstitial lung disease 2 tag.SummaryDifference0.1%

- Check95 days agoChange DetectedSite revision updated from v3.4.3 to v3.5.0; the update is visible in the footer and does not alter study details or page content.SummaryDifference0.0%

Stay in the know with updates to Nintedanib IPF Trial: Twice Daily vs Placebo
Enter your email address, and we'll notify you when there's something new on the Nintedanib IPF Trial: Twice Daily vs Placebo page.